Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Standard

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. / Karn, Thomas; Pusztai, Lajos; Holtrich, Uwe; Iwamoto, Takayuki; Shiang, Christine Y; Schmidt, Marcus; Müller, Volkmar; Solbach, Christine; Gaetje, Regine; Hanker, Lars; Ahr, Andre; Liedtke, Cornelia; Ruckhäberle, Eugen; Kaufmann, Manfred; Rody, Achim.

In: PLOS ONE, Vol. 6, No. 12, 12, 2011, p. 28403.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Karn, T, Pusztai, L, Holtrich, U, Iwamoto, T, Shiang, CY, Schmidt, M, Müller, V, Solbach, C, Gaetje, R, Hanker, L, Ahr, A, Liedtke, C, Ruckhäberle, E, Kaufmann, M & Rody, A 2011, 'Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.', PLOS ONE, vol. 6, no. 12, 12, pp. 28403. https://doi.org/10.1371/journal.pone.0028403

APA

Karn, T., Pusztai, L., Holtrich, U., Iwamoto, T., Shiang, C. Y., Schmidt, M., Müller, V., Solbach, C., Gaetje, R., Hanker, L., Ahr, A., Liedtke, C., Ruckhäberle, E., Kaufmann, M., & Rody, A. (2011). Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. PLOS ONE, 6(12), 28403. [12]. https://doi.org/10.1371/journal.pone.0028403

Vancouver

Bibtex

@article{608ea3a8a2184d3eaa568a82b6863d88,
title = "Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.",
abstract = "Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes.",
keywords = "Humans, Female, Cohort Studies, Reproducibility of Results, Predictive Value of Tests, Prognosis, Tumor Markers, Biological, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, Kaplan-Meier Estimate, *Gene Expression Profiling, Breast Neoplasms/drug therapy/*genetics, *Databases, Genetic, Genes, Neoplasm/genetics, Receptor, erbB-2/*deficiency/metabolism, Receptors, Estrogen/*deficiency/metabolism, Receptors, Progesterone/*deficiency/metabolism, Humans, Female, Cohort Studies, Reproducibility of Results, Predictive Value of Tests, Prognosis, Tumor Markers, Biological, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, Kaplan-Meier Estimate, *Gene Expression Profiling, Breast Neoplasms/drug therapy/*genetics, *Databases, Genetic, Genes, Neoplasm/genetics, Receptor, erbB-2/*deficiency/metabolism, Receptors, Estrogen/*deficiency/metabolism, Receptors, Progesterone/*deficiency/metabolism",
author = "Thomas Karn and Lajos Pusztai and Uwe Holtrich and Takayuki Iwamoto and Shiang, {Christine Y} and Marcus Schmidt and Volkmar M{\"u}ller and Christine Solbach and Regine Gaetje and Lars Hanker and Andre Ahr and Cornelia Liedtke and Eugen Ruckh{\"a}berle and Manfred Kaufmann and Achim Rody",
year = "2011",
doi = "10.1371/journal.pone.0028403",
language = "English",
volume = "6",
pages = "28403",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

RIS

TY - JOUR

T1 - Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

AU - Karn, Thomas

AU - Pusztai, Lajos

AU - Holtrich, Uwe

AU - Iwamoto, Takayuki

AU - Shiang, Christine Y

AU - Schmidt, Marcus

AU - Müller, Volkmar

AU - Solbach, Christine

AU - Gaetje, Regine

AU - Hanker, Lars

AU - Ahr, Andre

AU - Liedtke, Cornelia

AU - Ruckhäberle, Eugen

AU - Kaufmann, Manfred

AU - Rody, Achim

PY - 2011

Y1 - 2011

N2 - Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes.

AB - Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes.

KW - Humans

KW - Female

KW - Cohort Studies

KW - Reproducibility of Results

KW - Predictive Value of Tests

KW - Prognosis

KW - Tumor Markers, Biological

KW - Neoadjuvant Therapy

KW - Gene Expression Regulation, Neoplastic

KW - Kaplan-Meier Estimate

KW - Gene Expression Profiling

KW - Breast Neoplasms/drug therapy/genetics

KW - Databases, Genetic

KW - Genes, Neoplasm/genetics

KW - Receptor, erbB-2/deficiency/metabolism

KW - Receptors, Estrogen/deficiency/metabolism

KW - Receptors, Progesterone/deficiency/metabolism

KW - Humans

KW - Female

KW - Cohort Studies

KW - Reproducibility of Results

KW - Predictive Value of Tests

KW - Prognosis

KW - Tumor Markers, Biological

KW - Neoadjuvant Therapy

KW - Gene Expression Regulation, Neoplastic

KW - Kaplan-Meier Estimate

KW - Gene Expression Profiling

KW - Breast Neoplasms/drug therapy/genetics

KW - Databases, Genetic

KW - Genes, Neoplasm/genetics

KW - Receptor, erbB-2/deficiency/metabolism

KW - Receptors, Estrogen/deficiency/metabolism

KW - Receptors, Progesterone/deficiency/metabolism

U2 - 10.1371/journal.pone.0028403

DO - 10.1371/journal.pone.0028403

M3 - SCORING: Journal article

VL - 6

SP - 28403

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 12

M1 - 12

ER -